Clarunis University Center for Gastrointestinal and Liver Diseases, St. Clara Hospital and University Hospital Basel, Basel, Switzerland.
Department of Surgery, Cantonal Hospital Olten, Olten, Switzerland.
World J Surg. 2022 Mar;46(3):680-689. doi: 10.1007/s00268-021-06399-4. Epub 2021 Dec 27.
According to the common tenet, tumour progression is a chronological process starting with lymphatic invasion. In this respect, the meaning of bone marrow micrometastases (BMM) in patients with lymph node negative colon cancer (CC) is unclear. This study examines the relationship of isolated tumour cells (ITC) in sentinel lymph nodes (SLN) and BMM in patients in early CC.
BM aspirates were taken from both pelvic crests and in vivo SLN mapping was done during open oncologic colon resection in patients with stage I and II CC. Stainings were performed with the pancytokeratin markers A45-B/B3 and AE1/AE3 as well as H&E. The correlation between the occurrence of ITC+ and BMM+ and their effects on survival was examined using Cox regression analysis.
In a total of 78 patients with stage I and II CC, 11 patients (14%) were ITC+, 29 patients (37%) BMM+. Of these patients, only two demonstrated simultaneous ITC+ /BMM+. The occurrence of BMM+ was neither associated with ITC+ in standard correlation (kappa = - 0.13 [95% confidence interval [CI] = - 0.4-0.14], p = 0.342) nor univariate (odds ratio [OR] = 0.39, 95%CI:0.07-1.50, p = 0.180) or multivariate (OR = 0.58, 95%CI: 0.09-2.95, p = 0.519) analyses. Combined detection of ITC+ /BMM+ demonstrated the poorest overall (HR = 61.60, 95%CI:17.69-214.52, p = 0.032) and recurrence free survival (HR = 61.60, 95%CI: 17.69-214.5, p = 0.032).
These results indicate that simultaneous and not interdependent presence of very early lymphatic and haematologic tumour spread may be considered as a relevant prognostic risk factor for patients with stage I and II CC, thereby suggesting the possible need to reconsider the common assumptions on tumour spread proposed by the prevalent theory of sequential tumour progression.
根据普遍观点,肿瘤进展是一个从淋巴浸润开始的时间顺序过程。在这方面,淋巴结阴性结肠癌(CC)患者骨髓微转移(BMM)的意义尚不清楚。本研究检查了早期 CC 患者前哨淋巴结(SLN)中孤立肿瘤细胞(ITC)与 BMM 之间的关系。
在 I 期和 II 期 CC 患者的开放性肿瘤结肠切除术中,从两个骨盆嵴采集骨髓抽吸物,并进行体内 SLN 定位。使用泛细胞角蛋白标志物 A45-B/B3 和 AE1/AE3 以及 H&E 进行染色。使用 Cox 回归分析检查 ITC+和 BMM+的发生及其对生存的影响。
在总共 78 名 I 期和 II 期 CC 患者中,11 名患者(14%)为 ITC+,29 名患者(37%)为 BMM+。这些患者中,只有两名同时显示 ITC+/BMM+。BMM+的发生与标准相关性中的 ITC+既没有关联(kappa = -0.13 [95%置信区间(CI)= -0.4-0.14],p = 0.342),也没有单变量(优势比(OR)= 0.39,95%CI:0.07-1.50,p = 0.180)或多变量(OR = 0.58,95%CI:0.09-2.95,p = 0.519)分析。ITC+/BMM+的联合检测显示总生存(HR = 61.60,95%CI:17.69-214.52,p = 0.032)和无复发生存(HR = 61.60,95%CI:17.69-214.5,p = 0.032)最差。
这些结果表明,非常早期的淋巴和血液肿瘤播散的同时存在而非相互依存,可被视为 I 期和 II 期 CC 患者的一个相关预后危险因素,从而表明可能需要重新考虑由连续肿瘤进展的主流理论提出的关于肿瘤播散的普遍假设。